1275331

Glaxo Wellcome Manufacturing Pte Limited — FEI 3002807079

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 13, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Singapore (Singapore)

Additional Details

Mutual Recognition Agreement (MRA)